340B Advocacy Alliance Bulletin
The AHA today urged the Department of Health and Human Services to ensure hospitals currently participating in the 340B Drug Pricing Program continue to have access to the program despite changes in their payer mix as a result of the COVID-19 public health emergency.
The AHA yesterday
Replay of Available of Feb.
340B Advocacy Alliance Bulletin: Last Chance to Register for Today’s 340B Alliance Call at 3 p.m. ET
The AHA 340B Advocacy Alliance today, Feb. 22 at 3 p.m. ET will provide an update on the many legal cases and issues surrounding the 340B drug savings program. This call is for AHA members only, and you must register for the call in order to participate.
A U.S.
The AHA 340B Advocacy Alliance Feb. 22 at 3 p.m. ET will provide an update on the many legal cases and issues surrounding the 340B Drug Pricing Program.
The AHA, joined by member hospitals and health systems and other national organizations representing hospitals, yesterday filed petitions asking the U.S. Supreme Court to reverse appeals court decisions in two important cases for patients and providers.
The two cases being appealed to the U.S.…
Please contact your representatives and ask them to sign onto a
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Xavier Becerra, the nominee for Department of Health and Human Services Secretary, asking him to take immediate action to ensure that manufacturers are prohibited from imposing unilateral…
Yesterday counsel for AHA and the four other national groups participants and three individual hospital systems that sued the Department of Health and Human Services over its failure to halt drug company actions that undermine the 340B program sent letters demanding that the offending…